n/a
Article Publish Status: FREE
Abstract Title:

Exposure to fine particulate matter and temporal dynamics of episodic memory and depressive symptoms in older women.

Abstract Source:

Environ Int. 2019 Dec 24 ;135:105196. Epub 2019 Dec 24. PMID: 31881430

Abstract Author(s):

Andrew J Petkus, Diana Younan, Keith Widaman, Margaret Gatz, JoAnn E Manson, Xinhui Wang, Marc Serre, William Vizuete, Helena Chui, Mark A Espeland, Susan Resnick, Jiu-Chiuan Chen

Article Affiliation:

Andrew J Petkus

Abstract:

BACKGROUND: Emerging data suggests PM(particulate matter with aerodynamic diameter<2.5 μm) may be associated with both earlier declines in episodic memory (EM) and increased depressive symptoms in older adults. Although late-life depressive symptoms are associated with EM, no longitudinal studies have examined the inter-relationship among PM, depressive symptoms and EM.

METHODS: Older women (n = 2,202; aged 67-83 in 1999) enrolled in the Women's Health Initiative Study of Cognitive Aging completed up to eight annual assessments of depressive symptoms (15-item Geriatric Depression Scale) and EM (California Verbal Learning Test). A nationwide spatiotemporal model (1999-2010) was used to estimate ambient PMexposure at residential locations. Univariate and bivariate structural equation models (SEMs) for latent-change scores were used to examine how 3-year average PMpreceding each assessment affects the temporal dynamics and bidirectional relations of annual changes in depressive symptoms and EM.

RESULTS: In univariate SEMs, one inter-quartile (4.04 μg/m) increment of 3-year PMwas significantly (p < 0.05) associated with accelerated declines in verbal learning (List A trials 1-3: β = -1.48) and free-recall memory (short-delay: β = -1.43; long-delay: β = -1.11), but not with change in depressive symptoms (β = 0.12; p = 0.71). In bivariate SEMs, significant associationswere observed between PMand accelerated declines in EM measures (β = -1.44 to -0.99; p < 0.05) and between EM performance and changes in depressive symptoms (β = -0.08 to -0.05; p < 0.05), with significant indirect PMeffects on changes in depressive symptoms (β = 0.08-0.10; p < 0.05). These findings were robust with adjustment for multiple demographic, lifestyle, and clinical factors, and remained after excluding subjects with dementia or mild cognitive impairment. No associations were found between PMand change in depressive symptoms or depressive symptoms and subsequent EM decline.

CONCLUSIONS: Findings suggest that PMneurotoxicity may damage brain areas implicated in EM, followed by manifestation of depressive symptoms. Our data did not support depressive symptoms as the neuropsychological mediator of accelerated brain aging associated with PMexposure.

Study Type : Human Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.